Singles’ bars, classified personals and dating websites are a reflection, not only of the common human desire to find a mate, but of the sense of scarcity that seems to surround the hunt. Many people participate in dating activities in the hopes of finding that special someone, yet feel as though it is an impossible task.

However, thanks to an international team of psychologists, the solution may be closer than we think — within ourselves, to be exact.

BASINGSTOKE, England and PHILADELPHIA, February 12 /PRNewswire/ -- Shire plc (LSE: SHP)(NASDAQ: SHPGY)(TSX: SHQ), the global specialty biopharmaceutical company, will announce full year 2007 earnings on Thursday 21 February 2008.

Results press release will be issued at: 12:00 GMT / 07:00 EST Investor meeting and conference call time: 14:00 GMT / 09:00 EST

Investor & Analyst meeting and conference call:

Matthew Emmens, Chief Executive Officer, Angus Russell, Chief Financial Officer, Mike Cola, President, Specialty Pharmaceuticals and Sylvie Gregoire, President, Human Genetic Therapies will host the investor and analyst meeting and conference call at 14:00 GMT/9:00 EST.

JACKSONVILLE, Florida, February 12 /PRNewswire/ --

- New Keyboard aimed at reducing cross contaminations including Norovirus and MRSA

Seal Shield LLC announced that it has begun shipping the new SILVER SEAL(TM) Washable, Antimicrobial Keyboard. According to the company, the SILVER SEAL(TM) Keyboard is the world's first computer keyboard to be fully submersible, dishwasher safe, and manufactured from SILVER SEAL(TM) Antimicrobial plastic. The SILVER SEAL(TM) Keyboard has been created to help reduce the risk of cross contaminations, including Norovirus and the "superbug," MRSA. The SILVER SEAL(TM) Keyboard is the Antimicrobial version of the company's best selling, SEAL SHIELD(TM) Medical Grade Washable Keyboard (Patent Pending), which was introduced last year.

ROCHESTER, New York, February 12 /PRNewswire/ --

Lucid, Inc. (www.lucid-tech.com) today announced the launch of its secure VivaNet(R) telemedicine server and network. The network is designed to transfer and manage clinical data between dermatology practitioners using Lucid's non-invasive VivaScope(R) Confocal Imagers with pathologists or other medical specialists.

Lucid's VivaScope(R) confocal imager microscopes provide non-invasive, in-vivo cellular resolution images of skin. Dermatologists can use the images to form a clinical judgment for a variety of skin conditions -- without the need to excise tissue.

LEEDS, England, February 12 /PRNewswire/ --

- Teva UK Limited has Launched a New Website.

The new website, which is at http://www.tevauk.com, has been fully updated with a fresh new approach and contemporary design. Teva believes the new site will provide comprehensive information about the company to its customers, partners and employees alike.

How can today's wired, multitasking scientists ever compete with the great scientists of the past? One feature of Darwin's work as a scientist was that it proceeded slowly, very, very slowly. He wrote massive groundbreaking books, compiled huge amounts of data on orchids, barnacles, and Galapagos animals, but all over a long period of time. Scientists in Darwin's day had hours to kill on long voyages, took long walks out in the field, and waited while their scientific correspondence leisurely wended its way across oceans or continents.

Even in the first half of the 20th century, great scientists are famous for what they accomplished on long walks, hiking trips, and train rides. Niels Bohr would walk for hours around Copenhagen and come up with groundbreaking ideas, while Werner Heisenberg spent weeks every year hiking in the mountains. Even Richard Feynman, working in our more modern (but still pre-internet) era, insisted on long blocks of time to concentrate; he likened his thought process to building a house of cards, easily toppled by distraction and difficult to put back together.

Does that mean the kind of science we do in our overscheduled, multitasking world will never be the same as it was in the past? Certainly in one sense it won't - earlier generations of scientists had one distinct advantage we don't have today: Servants.

BRUSSELS, Belgium, February 12 /PRNewswire/ --

The European Commission's new "Green Package" of legislation on climate change and renewable energy represents a significant potential opportunity for European utilities, according to a report released by The Brattle Group and Trilemma UK.

The Green Package sets targets that represent a step change in the energy market: save 20% of energy, increase the share of renewable energy to 20%, and cut greenhouse gas emissions by at least 20%, all by 2020. The joint report highlights the huge uncertainties in these targets, which make investment decisions difficult and risky, particularly regarding new power stations.

WALTHAM, Massachusetts, February 12 /PRNewswire/ --

- Institutional Investor News Features David Fiske of Lewtan's European Office in Inaugural Publication Honoring the "10 Rising Stars of Securitization"

Lewtan Technologies, Inc., provider of asset-backed securities surveillance data, analytics, software, and content for the global securitization industry, today announced that product marketing manager David Fiske has been named by Institutional Investor News as one of its 10 Rising Stars of Securitization.

AMSTERDAM, February 12 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced that it will release its financial results for the full year 2007 on Wednesday, February 20, 2008 at 7:30 am Central European Time (CET). To discuss these results, the Company will conduct a conference call at 10 am CET. Netherlands Dial In: 0800-949-4517 (toll free); US Dial In: +1-866-291-4166 (toll free); UK Dial In: +44-207-107-0611. To listen to the conference call live via the internet, visit the investor relations portion of the AMT website at http://www.amtbiopharma.com. Please go to the website 15 minutes prior to the call to register, download and install the necessary audio software.

Prof. Camillo O. DI CICCO, M.D. XIth Congress of the European Academy of Dermatology and Venereology, Prague. The first studies of the disease go back to 1846 by B.C. Brodie, which describes a picture of lipomatosis symmetrical disseminated with interest of the neck in the job " Clinical Lectures on Surgery, Delivered at St George's Hospital " Philadelphya, Lea and Blanchard (pub) 1846 Pp 201-210. Subsequently such picture was described from Huguier (1855)), Founder (1863) and Vermeuil (1888). In the same year Otto W.